Kiniksa Pharmaceuticals International (KNSA) Gross Profit (QoQ) (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Gross Profit (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 4.85 Bn | 4.39 Bn | 193.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.78% |
| Dec 31, 2025 | 12.82% |
| Sep 30, 2025 | 16.21% |
| Jun 30, 2025 | 15.24% |
| Mar 31, 2025 | 14.60% |
| Dec 31, 2024 | 13.61% |
| Sep 30, 2024 | -4.37% |
| Jun 30, 2024 | 39.02% |
| Mar 31, 2024 | -6.15% |
| Dec 31, 2023 | 27.35% |
| Sep 30, 2023 | -9.12% |
| Jun 30, 2023 | 33.27% |
| Mar 31, 2023 | 130.87% |
| Dec 31, 2022 | -268.12% |
| Sep 30, 2022 | 320.17% |
| Jun 30, 2022 | -21.55% |
| Mar 31, 2022 | 88.00% |
| Dec 31, 2021 | 59.50% |
| Sep 30, 2021 | 78.08% |